Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 2 study is to investigate whether intravenous administration of
REOLYSIN therapeutic virus in combination with paclitaxel and carboplatin is effective and
safe in the treatment of metastatic melanoma.